Trade Show News

Stay updated with the latest trade show news through detailed press releases. Learn about upcoming events, key highlights, and industry trends. Get insights into significant trade show announcements, exhibitor information, and post-event analyses.

Oct 9, 2026 at 1:55 PM

AvionTEq Celebrates Successful MRO Asia-Pacific 2026 and Announces UTS100 Giveaway Winner

VAN NUYS, Calif.--(BUSINESS WIRE)--AvionTEq, a leading global provider of aviation test equipment and support solutions, successfully finished its MRO Asia-Pacific 2026 experience from September 22-24 at Singapore EXPO. At Booth 2106, AvionTEq showcased its innovations and services to visiting airlines, MRO entities, manufacturers, maintenance providers, and aviation professionals from Asia-Pacific countries as well as visitors from around the world. The event was a great way to reconnect with...
Oct 9, 2026 at 9:15 AM

Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up

MILAN--(BUSINESS WIRE)--Corcym's Perceval Plus sutureless aortic heart valve shows excellent durability, safety and quality of life at up to 7 years at EACTS meeting....
Oct 9, 2026 at 8:00 AM

DIC Commences Global Rollout of ECOVART™, a Low Solvent–Content Gravure Ink that Helps Improve Productivity

TOKYO--(BUSINESS WIRE)--DIC launches ECOVART™, helping packaging printers reduce solvent use, improve productivity and mitigate solvent procurement risks....
Oct 9, 2026 at 8:00 AM

Secretome Therapeutics to Present Phase 1 Clinical Data Evaluating STM-01 in Heart Failure with Preserved Ejection Fraction at HFSA Annual Scientific Meeting

PLANO, Texas--(BUSINESS WIRE)--Secretome Therapeutics, a clinical-stage biotechnology company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), today announced that clinical data from its Phase 1 study evaluating STM-01 in patients with heart failure with preserved ejection fraction (HFpEF) will be presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting.STM-01 is an investigational biologic therapy derived from neonatal cardiac progenito...
Oct 9, 2026 at 1:16 AM

Kioxia Introduces E1.L QLC-based SSDs for Hyperscale Data Centers

TOKYO--(BUSINESS WIRE)--Kioxia Corporation announced its first E1.L form factor SSD built with BiCS FLASH™ generation 8 QLC flash memory, KIOXIA LD4 Series Data Center SSD....
Oct 8, 2026 at 9:45 PM

ModelFront Announces OpenLoc, the Open TMS Built for AI

SAN FRANCISCO--(BUSINESS WIRE)--Today at Tech Week in San Francisco, ModelFront announced the launch of OpenLoc, the open TMS built for AI. With OpenLoc, localization teams can: Run raw MT and AI workflows with no AI tax. Use any LLM, with context and RAG, through an easy, powerful prompt builder. Get free integrations, similar to installing an app. Create dashboards from chat, or in other tools. Manage anything via system-wide MCP. Host themselves for free, or get enterprise hosting and suppor...
Oct 8, 2026 at 3:00 PM

Bayer to Present New Cardiac Amyloidosis and Heart Failure Data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Summary Bayer today announced that one late-breaking presentation along with five posters across its cardiovascular programs will be featured at the Heart Failure Society of America (HFSA) Annual Scientific Meeting in Phoenix, Arizona, from October 9-12, 2026. Key Facts A post-hoc analysis from the Phase III REVEAL study, which evaluated the investigational PET radiotracer I 124 evuzamitide for the sensitivity and specificity of cardiac amyloidosis based o...
Oct 8, 2026 at 3:00 PM

TD SYNNEX Unveils AI That Works Alongside Partners, Expanding PartnerFirst with Agentic Capabilities

FREMONT, Calif., & CLEARWATER, Fla.--(BUSINESS WIRE)--TD SYNNEX (NYSE: SNX) shared the next evolution of PartnerFirst for North American partners, introducing new agentic AI capabilities....
Oct 8, 2026 at 1:15 PM

LEO Pharma to Present 21 Posters Across Chronic Hand Eczema, Generalized Pustular Psoriasis, Atopic Dermatitis and Pyoderma Gangrenosum at the 2026 Fall Clinical Dermatology Conference

MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma, Inc., a global leader in medical dermatology, today announced its scientific program for the 2026 Fall Clinical Dermatology Conference, taking place October 8-11 in Las Vegas, Nevada. Among the 21 posters are presentations of new data on delgocitinib in chronic hand eczema (CHE), spesolimab in generalized pustular psoriasis (GPP), and tralokinumab in atopic dermatitis (AD). Other presentations include findings to characterize disease prevalence and bu...
Oct 8, 2026 at 1:12 PM

Pallas Textiles Brings Curated Colors, Nature-Inspired Patterns, and Exceptional Performance to Healing Environments

GREEN BAY, Wis.--(BUSINESS WIRE)--Healthcare designers are balancing an increasingly complex set of needs: creating welcoming spaces for patients, families, and caregivers while meeting demanding requirements for durability, cleanability, and sustainability. At Healthcare Design Conference + Expo 2026, Pallas Textiles will showcase how its portfolio brings together color, pattern, texture, and nature-inspired design to support healing environments throughout the care journey. From the first mom...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up